Skip to main content

Table 3 Baseline compared to 9 month Follow-up visit

From: Tele-monitoring reduces exacerbation of COPD in the context of climate change–a randomized controlled trial

Group

Telegroup, N = 27

P-value

Control group, N = 25

P-value

 

BL

9 M

Mean difference

 

BL

9 M

Mean difference

 

6MWT steps

522 ± 113

662 ± 86.4

140 ± 95.2

0.006*

553 ± 103

601 ± 88.7

48.3 ± 85.2

0.23

6MWT distance

377 ± 88.0

464 ± 60.5

87.0 ± 65.7

0.006*

377 ± 78.0

400 ± 72.4

23.9 ± 70.3

0.23

FEV1%

50.2 ± 15.0

52.7 ± 16.7

2.5 ± 5.2

0.10

52.6 ± 17.4

52.6 ± 19.8

-.07 ± 9.2

0.99

CAT

19.0 ± 6.9

16.0 ± 5.6

−2.9 ± 4.5

0.04*

17.6 ± 5.0

22.0 ± 6.9

4.4 ± 5.7

0.013*

  1. Characteristics of patient population baseline (BL) compared to 9-month follow-up; data is presented as Mean ± SD; group comparisons of measurements across different Randomization Groups were done using a paired student’s t-test; *statistical significance is set at P ≤ 0.05. 6MWT = 6-minute walk test; FEV1 (%) = Forced Expiratory Volume in one second% predicted; CAT = COPD Assessment Test.